BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31385047)

  • 1. No evidence of improved efficacy of covered stents over uncovered stents in percutaneous palliation of malignant hilar biliary obstruction: results of a prospective randomized trial.
    Dhondt E; Vanlangenhove P; Geboes K; Vandenabeele L; Van Cauwenberghe L; Defreyne L
    Eur Radiol; 2020 Jan; 30(1):175-185. PubMed ID: 31385047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Advantage of Expanded Polytetrafluoroethylene and Fluorinated Ethylene Propylene-Covered Stents over Uncovered Nitinol Stents for Percutaneous Palliation of Malignant Infrahilar Biliary Obstruction: Results of a Single-Center Prospective Randomized Trial.
    Dhondt E; Vanlangenhove P; De Man M; Huyck L; Defreyne L
    J Vasc Interv Radiol; 2020 Jan; 31(1):82-92. PubMed ID: 31627908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous palliation of pancreatic head cancer: randomized comparison of ePTFE/FEP-covered versus uncovered nitinol biliary stents.
    Krokidis M; Fanelli F; Orgera G; Tsetis D; Mouzas I; Bezzi M; Kouroumalis E; Pasariello R; Hatzidakis A
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):352-61. PubMed ID: 20467870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ePTFE/FEP-covered metallic stents for palliation of malignant biliary disease: can tumor ingrowth be prevented?
    Hatzidakis A; Krokidis M; Kalbakis K; Romanos J; Petrakis I; Gourtsoyiannis N
    Cardiovasc Intervent Radiol; 2007; 30(5):950-8. PubMed ID: 17508236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction.
    Bezzi M; Zolovkins A; Cantisani V; Salvatori FM; Rossi M; Fanelli F; Rossi P
    J Vasc Interv Radiol; 2002 Jun; 13(6):581-9. PubMed ID: 12050298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous unilateral biliary metallic stent placement in patients with malignant obstruction of the biliary hila and contralateral portal vein steno-occlusion.
    Son RC; Gwon DI; Ko HK; Kim JW; Ko GY
    Korean J Radiol; 2015; 16(3):586-92. PubMed ID: 25995688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of malignant biliary obstruction: technical and clinical results using an expanded polytetrafluoroethylene fluorinated ethylene propylene (ePTFE/FEP)-covered metallic stent after 6-year experience.
    Fanelli F; Orgera G; Bezzi M; Rossi P; Allegritti M; Passariello R
    Eur Radiol; 2008 May; 18(5):911-9. PubMed ID: 18204844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ePTFE/FEP stents for malignant biliary obstruction.
    Hui A; Krokidis M
    BMJ Support Palliat Care; 2022 Jul; 12(e2):e174-e177. PubMed ID: 32054643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
    Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
    Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant biliary obstruction: treatment with ePTFE-FEP- covered endoprostheses initial technical and clinical experiences in a multicenter trial.
    Schoder M; Rossi P; Uflacker R; Bezzi M; Stadler A; Funovics MA; Cejna M; Lammer J
    Radiology; 2002 Oct; 225(1):35-42. PubMed ID: 12354981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly designed uncovered biliary stent for palliation of malignant obstruction: results of a prospective study.
    Lawrence C; Nieto J; Parsons WG; Roy A; Guda NM; Steinberg SE; Hasan MK; Bucobo JC; Nagula S; Dey ND; Buscaglia JM;
    BMC Gastroenterol; 2020 Jun; 20(1):184. PubMed ID: 32522161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous unilateral placement of biliary covered metallic stent in patients with malignant hilar biliary obstruction and contralateral portal vein occlusion.
    Yi R; Gwon DI; Ko GY; Yoon HK; Kim JH; Shin JH; Sung KB
    Acta Radiol; 2012 Sep; 53(7):742-9. PubMed ID: 22850575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous stent placement for malignant hilar biliary obstruction: side-by-side versus stent-in-stent technique.
    Zhou WZ; Liu S; Yang ZQ; Xian YT; Xu HD; Wu JZ; Shi HB
    BMC Gastroenterol; 2020 Jun; 20(1):174. PubMed ID: 32503426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous use of ePTFE/FEP-covered metallic stent for palliation of malignant biliary obstruction.
    Zurstrassen CE; Santos AC; Tyng CJ; Matushita JP; Coimbra FJ; Diniz AL; Ribeiro HS; Costa WL; Lima DC
    Minim Invasive Ther Allied Technol; 2014 Dec; 23(6):366-73. PubMed ID: 25025653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
    Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
    AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the partially covered nitinol "ComVi" stent for malignant non hilar biliary obstruction.
    Perri V; Boškoski I; Tringali A; Familiari P; Marchese M; Lee DK; Jang SI; Han J; Kim HG; Mutignani M; Onder G; Costamagna G
    Dig Liver Dis; 2013 Apr; 45(4):305-9. PubMed ID: 23218991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Percutaneous Biliary Covered Stent Placement in Patients with Malignant Biliary Hilar Obstruction; Correlation with Liver Function.
    Hyun H; Choi SY; Kim KA; Ko SB
    Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1298-305. PubMed ID: 27224987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study.
    Kullman E; Frozanpor F; Söderlund C; Linder S; Sandström P; Lindhoff-Larsson A; Toth E; Lindell G; Jonas E; Freedman J; Ljungman M; Rudberg C; Ohlin B; Zacharias R; Leijonmarck CE; Teder K; Ringman A; Persson G; Gözen M; Eriksson O
    Gastrointest Endosc; 2010 Nov; 72(5):915-23. PubMed ID: 21034892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of percutaneous Y-configured covered stent placement for malignant hilar biliary obstruction: a prospective, pilot study.
    Gwon DI; Ko GY; Yoon HK; Kim YJ; Kim TH; Lee WH; Sung KB
    J Vasc Interv Radiol; 2012 Apr; 23(4):528-34. PubMed ID: 22341884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction.
    Kim JY; Ko GB; Lee TH; Park SH; Lee YN; Cho YS; Jung Y; Chung IK; Choi HJ; Cha SW; Moon JH; Cho YD; Kim SJ
    Gut Liver; 2017 May; 11(3):440-446. PubMed ID: 28208003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.